Monashee Investment Management »

Bluebird Bio shares owned by Monashee Investment Management

Quarter-by-quarter ownership of Bluebird Bio (BLUE) shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in Bluebird Bio

Tip: Access up to 7 years of quarterly data

All positions including Bluebird Bio held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bluebird Bio by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $690k 500k 1.38
2020-06-30 $7.9M 130k 61.04
2017-12-31 $6.7M 38k 178.11
2017-06-30 $13M 125k 105.05

More positions owned by Monashee Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds Total Stk Mkt (VTI)
Structure Therapeutics Sponsored Ads (GPCR)
Aercap Holdings Nv SHS (AER)
PG&E Corporation (PCG)
Korro Bio (KRRO)
Eyepoint Pharmaceuticals Com New (EYPT)
Celldex Therapeutics Com New (CLDX)
Roivant Sciences SHS (ROIV)

View all positions for Monashee Investment Management

Top funds holding Bluebird Bio

Vanguard Group
Alyeska Investment Group
Norges Bank Investment Management
Millennium Management
Palo Alto Investors
Dimensional Fund Advisors
Two Sigma Investments
Bleichroeder
Citadel Advisors
Hudson Bay Capital Management
Partner Fund Management
Jpmorgan Chase & Co
Frazier Life Sciences Management
Tang Capital Management
Bank of America Corporation

View all funds holding Bluebird Bio